Exploring interleukin-6, lipopolysaccharide-binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depression

Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial

(2021) Maria Antonietta Nettis et al.   NEUROPSYCHOPHARMACOLOGY

Inflammatory Markers in Depression: a Meta-Analysis of Mean Differences and Variability in 5,166 Patients and 5,083 Controls

(2020) Emanuele F. Osimo et al.   BRAIN BEHAVIOR AND IMMUNITY

Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials

(2020) Robson Zazula et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Immunoneuropsychiatry — novel perspectives on brain disorders

(2019) Katrin Pape et al.   Nature Reviews Neurology

Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression

(2019) Roger S. McIntyre et al.   JAMA Psychiatry

Biomarker-Guided Anti-inflammatory Therapies

(2019) Michael Berk et al.   JAMA Psychiatry

Cytokine Research in Depression: Principles, Challenges, and Open Questions

(2019) Hubertus Himmerich et al.   Frontiers in Psychiatry

Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials

(2018) Joshua D. Rosenblat et al.   JOURNAL OF AFFECTIVE DISORDERS

Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis

(2018) Magdalena Więdłocha et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Depression

(2018) Gin S Malhi et al.   LANCET

Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial

(2017) Muhammad I Husain et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Oxidative stress, inflammation and treatment response in major depression

(2017) Daniel Lindqvist et al.   PSYCHONEUROENDOCRINOLOGY

Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor

(2017) Kyoko Hasebe et al.   ACTA NEUROPSYCHIATRICA

Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety- and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice

(2016) Jafar Majidi et al.   BRAIN RESEARCH BULLETIN

Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor

(2016) Thomas Möller et al.   GLIA

From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways

(2016) G B Rogers et al.   MOLECULAR PSYCHIATRY

Immune mechanisms linked to depression via oxidative stress and neuroprogression

(2015) Nataliia Bakunina et al.   IMMUNOLOGY

Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial

(2015) Muhammad I. Husain et al.   Trials

Minocycline: far beyond an antibiotic

(2013) N Garrido-Mesa et al.   BRITISH JOURNAL OF PHARMACOLOGY

Determinants of Serum Concentrations of Lipopolysaccharide-Binding Protein (LBP) in the Adult Population: The Role of Obesity

(2013) Arturo Gonzalez-Quintela et al.   PLoS One

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study

(2012) Seyed-Hesameddin Abbasi et al.   JOURNAL OF AFFECTIVE DISORDERS

Does minocycline have antidepressant effect?

(2008) Chi-Un Pae et al.   BIOMEDICINE & PHARMACOTHERAPY

Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia

(2008) Christopher J Henry et al.   Journal of Neuroinflammation